Cambio received a price reduction of 1.5 billion after procurement – Systematic appealed but was rejected

Cambio received the maximum dividend on 33 out of 44 requirements in the evaluation, which led to the company's tender sum being reduced by approximately 1.5 billion. Danish Systematic, on the other hand, received zero kroner in price deductions for 33 claims, which the newspaper Dagens Medicin was the first to report on.

Appealed the deal

The company Systematic, headquartered in Aarhus, has long supplied advanced IT systems both to the Danish defence, NATO countries and the Danish healthcare system. The company appealed the deal but was denied. There it is difficult to understand how the system could be considered so deficient.

- I am cursed. Both on their own behalf but also on behalf of the Swedish taxpayers. I mean that you are missing out on something that was both better and cheaper, says Henrik Rosenberg Rasmussen, customer manager at Systematic.

Systematic's journal system is the largest in Denmark and is used in three of the country's five regions.

- We have delivered corresponding systems to several university hospitals and regions in Denmark. More than 20 hospitals have extensive experience with the system and have had good processes around it. So I cannot understand how it could be considered without value, says Henrik Rosenberg Rasmussen.

Had "flaws in their descriptions"

According to Region Stockholm, quality was highly valued and Systematic had "flaws in its descriptions" in the tender.

Gertrud Ocklin, head of unit at the regional management office, does not want to appear for an interview, but refers in an email to the legal review: "The court was able to establish that the procurement was carried out in fair competition based on requirements based on the needs of the businesses and in accordance with current legislation".

She also writes that Cambio met the goals with "complete, clear and customized descriptions that contained no or only minor flaws."

On Gotland and in Stockholm, Cosmic is to be introduced at the end of 2029. The agreement, worth close to 2.4 billion, is valid until November 2037 and can then be extended by up to 4 years.